Bioclinica was honored to host Congressman Patrick Meehan representing the 7th Congressional District in Pennsylvania in a visit to our Audubon, Pennsylvania offices on August 28. Congressman Meehan met with Bioclinica senior leadership, including our CEO Dr. John Hubbard, who is the 2017 Chairman of the Association of Clinical Research Organizations (ACRO), joined by ACRO Executive Director Douglas Peddicord. The discussion provided a view into the biopharma industry and Bioclinica’s role in advancing drug development by employing an approach that combines science and technology.
Congressman Patrick Meehan visits with Bioclinica staff joined by ACRO Executive Director Douglas Peddicord
During his visit, Congressman Meehan also participated in a town hall gathering with staff, many of whom reside within his district covering parts of southeastern Pennsylvania. "The life sciences industry is making a significant economic impact in our region as well as important contributions globally in people's health," said Congressman Meehan. "I appreciate this opportunity to see Bioclinica's operation, innovation, and remarkable work you do in bringing new cures to people in need."
Congressman Meehan hears from Bioclinica CEO John Hubbard, PhD and other company executives about Bioclinica's contributions, leading to new cures
Dr. Hubbard recognized Congressman Meehan's ongoing support of the biopharma industry and representation on Capitol Hill saying, "We appreciate all you do in support of our challenges and opportunities in the development of new cures." One such effort was the introduction of the Domestic Research Enhancement Act of 2017 with co-sponsors Rep George Holding and G.K. Butterfield of North Carolina. The Act modernizes the research and development tax credit to recognize the essential role contract research plays in the development of new pharmaceuticals, biologics, and medical devices.